SynCore Biotechnology (Taiwan) Price on December 12, 2024

4192 Stock  TWD 35.60  0.45  1.28%   
If you're considering investing in SynCore Stock, it is important to understand the factors that can impact its price. As of today, the current price of SynCore Biotechnology stands at 35.60, as last reported on the 12th of December 2024, with the highest price reaching 35.60 and the lowest price hitting 35.05 during the day. SynCore Biotechnology owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.13, which indicates the firm had a -0.13% return per unit of risk over the last 3 months. SynCore Biotechnology Co exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate SynCore Biotechnology's Variance of 1.82, coefficient of variation of (971.10), and Risk Adjusted Performance of (0.07) to confirm the risk estimate we provide.
  
SynCore Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1333

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns4192

Estimated Market Risk

 1.32
  actual daily
11
89% of assets are more volatile

Expected Return

 -0.18
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.13
  actual daily
0
Most of other assets perform better
Based on monthly moving average SynCore Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SynCore Biotechnology by adding SynCore Biotechnology to a well-diversified portfolio.

SynCore Biotechnology Valuation on December 12, 2024

It is possible to determine the worth of SynCore Biotechnology on a given historical date. On December 12, 2024 SynCore was worth 35.05 at the beginning of the trading date compared to the closed value of 35.6. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of SynCore Biotechnology stock. Still, in general, we apply an absolute valuation method to find SynCore Biotechnology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of SynCore Biotechnology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against SynCore Biotechnology's related companies.
 Open High Low Close Volume
  35.05    35.60    35.05    35.60    7,000  
12/12/2024
  35.05    35.60    35.05    35.60    0.00  
Backtest SynCore Biotechnology  |  SynCore Biotechnology History  |  SynCore Biotechnology Valuation   Previous
Open Value
35.05
35.6
Closing Value
38.99
Upside

SynCore Biotechnology Trading Date Momentum on December 12, 2024

On December 12 2024 SynCore Biotechnology Co was traded for  35.60  at the closing time. The highest price during the trading period was 35.60  and the lowest recorded bid was listed for  35.05 . There was no trading activity during the period 0.0. Lack of trading volume on December 12, 2024 did not result in any price rise and fall. The trading price change to the current price is 1.54% .

SynCore Biotechnology Fundamentals Correlations and Trends

By evaluating SynCore Biotechnology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among SynCore Biotechnology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. SynCore financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About SynCore Biotechnology Stock history

SynCore Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for SynCore is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in SynCore Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing SynCore Biotechnology stock prices may prove useful in developing a viable investing in SynCore Biotechnology
,Ltd, a biopharmaceutical company, engages in the research and development, manufacture, and marketing of drugs in the areas of oncology, ophthalmology, dermatology, and infectious diseases in Taiwan and internationally. The company was founded in 2008 and is headquartered in Yilan, Taiwan. SYNCORE BIOTECHNOL operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 81 people.

SynCore Biotechnology Stock Technical Analysis

SynCore Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of SynCore Biotechnology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of SynCore Biotechnology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

SynCore Biotechnology Period Price Range

Low
December 12, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

SynCore Biotechnology Co cannot be verified against its exchange. Please verify the symbol is currently traded on Taiwan OTC Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

SynCore Biotechnology December 12, 2024 Market Strength

Market strength indicators help investors to evaluate how SynCore Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading SynCore Biotechnology shares will generate the highest return on investment. By undertsting and applying SynCore Biotechnology stock market strength indicators, traders can identify SynCore Biotechnology Co entry and exit signals to maximize returns

SynCore Biotechnology Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for SynCore Biotechnology's price direction in advance. Along with the technical and fundamental analysis of SynCore Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of SynCore to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for SynCore Stock Analysis

When running SynCore Biotechnology's price analysis, check to measure SynCore Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SynCore Biotechnology is operating at the current time. Most of SynCore Biotechnology's value examination focuses on studying past and present price action to predict the probability of SynCore Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SynCore Biotechnology's price. Additionally, you may evaluate how the addition of SynCore Biotechnology to your portfolios can decrease your overall portfolio volatility.